Movatterモバイル変換

[0]ホーム

Jump to content

EHNA

Edit links

From Wikipedia, the free encyclopedia

Chemical compound

This articlemay be too technical for most readers to understand. Pleasehelp improve it tomake it understandable to non-experts, without removing the technical details.(March 2021) (Learn how and when to remove this message)

Pharmaceutical compound

EHNA
Identifiers

IUPAC name 3-(6-aminopurin-9-yl)nonan-2-ol
CAS Number	59262-86-1
PubChemCID	3206
ChemSpider	3094
ChEMBL	ChEMBL50378^Y
CompTox Dashboard(EPA)	DTXSID70110044
Chemical and physical data
Formula	C₁₄H₂₃N₅O
Molar mass	277.372 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCCCCCC(C(C)O)n1cnc2c1ncnc2N
InChI InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17) Key:IOSAAWHGJUZBOG-UHFFFAOYSA-N
(verify)

EHNA (erythro-9-(2-hydroxy-3-nonly)adenine) is a potentadenosine deaminase inhibitor,^[1] which also acts as aphosphodiesterase inhibitor that selectively inhibitsphosphodiesterase type 2 (PDE2).^[2]^[3]

References

[edit]

^"Sigma Aldrich". Retrieved16 January 2013.
^Podzuweit T, Nennstiel P, Müller A (September 1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine".Cellular Signalling.7 (7):733–8.doi:10.1016/0898-6568(95)00042-N.PMID 8519602.
^Méry PF, Pavoine C, Pecker F, Fischmeister R (July 1995)."Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes"(PDF).Molecular Pharmacology.48 (1):121–30.doi:10.1016/S0026-895X(25)10036-9.PMID 7623766.

v t e Phosphodiesterase inhibitors
PDE1	MMPX SCH-51866 Vinpocetine
PDE2	BAY 60-7550 Carbazeran EHNA Oxindole PDP
PDE3	Adibendan Amrinone (inamrinone) Anagrelide Benafentrine Bucladesine Carbazeran Cilostamide Cilostazol Enoximone Ensifentrine Imazodan KMUP-1 Meribendan Milrinone Olprinone Parogrelil Pimobendan Pumafentrine Quazinone RPL-554 Siguazodan Trequinsin Vesnarinone Zardaverine
PDE4	Apremilast Arofylline Atizoram Benafentrine Catramilast CC-1088 CDP-840 CGH-2466 Cilomilast Cipamfylline Crisaborole Denbutylline Difamilast Drotaverine Ensifentrine Etazolate Filaminast Glaucine HT-0712 ICI-63197 Indimilast Irsogladine Lavamilast Lirimilast Lotamilast Luteolin Mesembrenone Mesembrine Mesopram Oglemilast Piclamilast Pumafentrine Revamilast Ro 20-1724 Roflumilast Rolipram Ronomilast RPL-554 RS-25344 Tetomilast Tofimilast YM-976 Zardaverine
PDE5	Acetildenafil Aildenafil Avanafil Beminafil Benzamidenafil Dasantafil Icariin Gisadenafil Homosildenafil Lodenafil Mirodenafil MY-5445 Nitrosoprodenafil Norcarbodenafil SCH-51866 Sildenafil Sulfoaildenafil T-0156 Tadalafil Udenafil Vardenafil
PDE7	BRL-50481
PDE9	BAY 73-6691 PF-04447943 Paraxanthine
PDE10	Balipodect Mardepodect MK-8189 Papaverine TC-E 5005 Tofisopam
PDE11	BC11-38
Non-selective	Aminophylline Caffeine Choline theophyllinate CPX Dipyridamole Doxofylline Enprofylline Ibudilast IBMX Luteolin Pentoxifylline Propentofylline Theobromine Theophylline Zaprinast
Unsorted	Diazepam Diprophylline DPCPX Furafylline Lisofylline MDL-12330A Moxaverine Oxagrelate Pentifylline Proxyphylline Quercetin Satigrel Tolafentrine Trapidil
See also:Receptor/signaling modulators

Thispharmacology-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=EHNA&oldid=1282703396"

Categories:

Hidden categories:

[8]ページ先頭